Cyclophosphamide

POF1B actin binding protein ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34995765 Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis. 2022 Apr 1
2 35177657 TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. 2022 Feb 17 1
3 33613687 Moxibustion against Cyclophosphamide-Induced Premature Ovarian Failure in Rats through Inhibiting NLRP3-/Caspase-1-/GSDMD-Dependent Pyroptosis. 2021 1
4 34053364 Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy. 2021 Aug 2
5 32083540 Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. 2020 May-Jun 2
6 32558438 Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study. 2020 Jun 3
7 29615109 Human chorionic plate-derived mesenchymal stem cells transplantation restores ovarian function in a chemotherapy-induced mouse model of premature ovarian failure. 2018 Apr 3 1
8 28807003 Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. 2017 Aug 14 1
9 26621134 Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand. 2016 Apr 1
10 27347041 Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway. 2016 Jul 1
11 27485835 Telocytes as potential targets in a cyclophosphamide-induced animal model of premature ovarian failure. 2016 Sep 2
12 23028242 CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. 2012 1
13 21868068 Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases. 2011 Dec 1
14 16686258 Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. 2006 1
15 16142702 Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. 2005 Sep 2